17 Capital Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
17 Capital Partners's CDNA Position: Q2 2022 in Review
17 Capital Partners sold out of CareDx (CDNA) in Q2 2022, closing a stake of 9,550 shares — an estimated $353K sold.
17 Capital Partners first reported a position in CDNA in Q2 2021 and held it in 2 quarters. The position peaked at $506K in Q2 2021. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.
- 17 Capital Partners reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
- 17 Capital Partners sold 9,550 CareDx shares in Q2 2022, an estimated $353K.
- 17 Capital Partners first reported a position in CareDx in Q2 2021 and held it in 2 quarters.
- 17 Capital Partners's CareDx position peaked at $506K in Q2 2021.
- 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.
Based on 17 Capital Partners's 13F filing for Q2 2022, filed 8 Jul 2022.